Prescription drug · ANDA
Diethylpropion Hydrochloride ER (diethylpropion hydrochloride) NDC 17224-760
Diethylpropion hydrochloride 75 mg/1 · Tablet, Extended release · Oral · Calvin Scott & Co., Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 17224-760-07 | 17224076007 | 7 TABLET, EXTENDED RELEASE in 1 BOTTLE (17224-760-07)Marketed from Oct 24, 2011 | |
| 17224-760-28 | 17224076028 | 28 TABLET, EXTENDED RELEASE in 1 BOTTLE (17224-760-28)Marketed from Oct 24, 2011 | |
| 17224-760-30 | 17224076030 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (17224-760-30)Marketed from Oct 24, 2011 | |
| 17224-760-56 | 17224076056 | 56 TABLET, EXTENDED RELEASE in 1 BOTTLE (17224-760-56)Marketed from Oct 24, 2011 | |
| 17224-760-84 | 17224076084 | 84 TABLET, EXTENDED RELEASE in 1 BOTTLE (17224-760-84)Marketed from Oct 24, 2011 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Diethylpropion Hydrochloride ERSuffix: ER
- Generic name (nonproprietary)
- diethylpropion hydrochloride
- Active ingredients
- Diethylpropion hydrochloride — 75 mg/1
- Dosage form
- Tablet, Extended release
- Route
- Oral
- Labeler
- Calvin Scott & Co., Inc.
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 091680
- Marketing start
- Listing expires
- DEA schedule
- CIV
- Other FDA classes
- Appetite Suppression (Physiologic effect)Increased Sympathetic Activity (Physiologic effect)
- Identifiers
- Product ID 17224-760_2efc1ef8-67d5-08c4-e063-6394a90ab458SPL ID 2efc1ef8-67d5-08c4-e063-6394a90ab458SPL set ID d6cde8cc-26ae-4087-8eac-b11192749cc5RxCUI 978668UNII 19V2PL39NG
- Pharmacologic class
- Sympathomimetic Amine Anorectic
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N417224076007followed by a unit qualifier and the quantityPackage 17224-0760-07. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Diethylpropion hydrochloride extended release tablets, 75 mg are indicated in the management of exogenous obesity as a short-term adjunct (a few weeks) in a regimen of weight reduction based on caloric restriction in patients with an initial body mass index (BMI) of 30 kg/m 2 or higher and who have not responded to appropriate weight reducing regimen (diet and/or exercise) alone. Below is a chart of BMI based on various heights and weights. BMI is calculated by taking the patient’s weight, in kilograms (kg), divided by the patient’s height, in meters (m), squared. Metric conversions are as follows: pounds divided by 2.2 = kg; inches x 0.0254 = meters. Body Mass Index (B…
Excerpt only. Read the full label for complete information.
- openFDA data updated
Med-Code stores this record for up to 24 hours before requesting it again.
Reference information only. Verify codes and billing rules against the applicable payer and official source before submitting a claim. How Med-Code handles data.